Background and objective: Breathing pattern disorder (BPD) can co-exist with and mimic asthma, acting to amplify symptoms and confound assessment of disease control, resulting in inappropriate treatment escalation. The aim of this research was to report the utility of a novel breathing pattern assessment tool (BPAT) to detect BPD in treatment-refractory asthma. Methods: As a component of a multidisciplinary assessment, adult patients referred with treatment-refractory asthma underwent respiratory physiotherapy assessment to diagnose BPD. Based on this assessment, patients were classified as having asthma, asthma + BPD or BPD alone. BPAT data were collected in addition to questionnaire data (Asthma Quality of Life Questionnaire (AQLQ) and Nijmegen Questionnaire (NQ)), pulmonary function and an assessment of exercise capacity. Results: Data were retrospectively analysed for 150 (female; 69%) patients, mean (SD) age of 43 (14) years; characterized as asthma-only (n = 54, 36%), asthma + BPD (n = 63, 42%) and BPD-only (n = 33, 22%). Of the total population, 113 (76%) had an NQ score ≥23, but of these only 68% had physiotherapy evidence of BPD. Exercise capacity and AQLQ were lower in the asthma + BPD group than in the asthmaonly group (P < 0.05), whilst lung function was similar between groups. Sensitivity analysis indicated that a BPAT score of ≥4 corresponded to a sensitivity of 0.92 and a specificity of 0.75 for diagnosis of BPD in this cohort. Conclusion: Breathing pattern irregularities are highly prevalent in individuals referred with treatmentrefractory asthma and can be characterized using the BPAT. Further work is needed to determine interobserver and within-subject variability and ensure the BPAT is a robust clinical tool.
INTRODUCTION
Breathlessness is a key feature in asthma, yet in some cases, it remains unresponsive to escalation in asthma treatment. 1 It is recognized that in such cases, the coexistence of other conditions may contribute to the aetiology of this symptom and impact quality of life. 2 One such condition is dysfunctional breathing (DB), defined as an 'alteration in the normal biomechanical pattern(s) of breathing, that results in intermittent/ chronic symptoms, which may be both respiratory and non-respiratory' 3 and a propensity to hyperventilation with subjective and psychological impact. 4 It is now recognized that DB is a prevalent co-morbidity in asthma. [5] [6] [7] Indeed, in some series, DB has been reported to be present in as many as one-fifth of individuals with asthma. 8 The presence of DB in asthma is known to have a detrimental impact on quality of life and can confound accurate assessment of asthma control by amplifying symptomatology. 9, 10 At the same time, targeted physiotherapy intervention for DB has been shown to improve asthma-related quality of life. 
SUMMARY AT A GLANCE
Breathing pattern disorder (BPD) can coexist with and mimic asthma, amplifying symptoms, leading to inappropriate treatment escalation. This study reveals that BPD is highly prevalent in treatmentrefractory asthma and can be characterized using a breathing pattern assessment tool (BPAT). The BPAT is easy to complete and promotes physiotherapy intervention.
therefore, accurate detection of DB in asthma is important in order to optimize both assessment and treatment.
At the current time, there is no simple measure to objectively characterize the breathing pattern disorder (BPD) abnormalities that underpin DB. 3 A questionnaire-based approach, utilizing the Nijmegen Questionnaire 12 (NQ), with a diagnostic cut-off level ≥23/64, was originally developed to diagnose hyperventilation syndrome; however, it has been subsequently widely employed to diagnose DB. 4 This approach is potentially confounded by the influence of overlapping symptoms, common to both DB and asthma. 13 Moreover, it provides no objective characterization of the cardinal feature of DB, namely irregularities in breathing pattern.
It is possible to measure breathing pattern by assessing changes in amplitude and frequency of tidal volume 14 using several techniques (e.g. optical electronic plethysmography and manual assessment of respiratory motion 15, 16 ). These techniques, however, frequently require specialist equipment and expertise and are neither widely available nor easy to apply in everyday clinical practice. At the present time, there is no simple, easy to apply, assessment instrument to detect BPD.
We describe the utility of a simple practical assessment instrument, the Brompton breathing pattern assessment tool (BPAT), that we have used routinely in our clinical practice, to assess the core features present in BPD; for example, respiratory rate (RR) and rhythm, noise of breathing and thoracic movement. In this study, we report BPAT data collected during the assessment of a cohort of individuals completing programmed investigation as part of a diagnostic work-up for severe asthma.
METHODS

Study population and design
We retrospectively evaluated routinely collected clinical data for adult patients (all aged >16 years) completing a systematic assessment of refractory asthma. This process of evaluation is considered the gold-standard diagnostic approach in the assessment of severe asthma 17 and comprises a number of investigations (see below).
The project was registered with the Royal Brompton and Harefield NHS Foundation Trust service evaluation team (# RBH 1074). All data that were analysed were collected as part of our standard care.
Systematic assessment of severe asthma
During the systematic assessment of asthma, individuals complete a series of investigations that include but are not limited to: skin prick testing to the common aeroallergens, pulmonary function testing (PFT) AE bronchodilator reversibility AE bronchoprovocation testing, measurement of fractional exhaled nitric oxide and pulmonary and cardiac imaging, where relevant. They also complete questionnaires to evaluate asthma quality of life (Asthma Quality of Life Questionnaire (AQLQ)) 18 and breathlessness (NQ and Dyspnoea 12 Questionnaire (D12)). 19 A specialist respiratory physiotherapist routinely evaluates patients in order to assess breathing pattern (including BPAT data). A diagnosis of BPD is based on this component of the clinical assessment, that is, physiotherapy diagnostic impression. As part of the physiotherapy assessment, patients also routinely complete an assessment of exercise capacity (6-min walk test (6MWT) reported as 6MWT distance (6MWTD)) expressed as % predicted. 20 All patients are reviewed by a specialist asthma physician in an multi-disciplinary team (MDT) structure, with a diagnosis of asthma based on an assimilation of results and objective evidence of airflow obstruction AE airway hyper-reactivity AE airway inflammation.
BPAT
The BPAT is a tabulated means of collating data obtained at respiratory physiotherapy assessment (Appendix S1, Supplementary Information). Assessment components include (i) evaluation of chest/abdominal wall movement, noise of (ii) inspiratory and (iii) expiratory flow, (iv) channel of inspiration and expiration, (v) signs of air hunger (yawning, sighing and deeper breaths), (vi) RR and (vii) rhythm. Each component is given a score from 0 to 2, based on features consistent with expected normal (0) versus that present in severe DB (2) , giving a total score of between 0 and 14. The BPAT is completed with a patient positioned, as per the standard assessment of resting breathing pattern (i.e. sat comfortably in a supported seat for at least 5 min) and takes approximately 1 min to collate.
Statistical analysis
Baseline characteristics for asthma-only (i.e. no evidence of BPD on physiotherapy assessment), BPD-only (no supporting evidence of asthma at SARA) and asthma + BPD groups were compared using independent t-tests for normally distributed continuous data, or using the Mann-Whitney U-test for non-parametric continuous data. Categorical data were compared using Pearson chi-square or Fisher's exact test.
The ability of BPAT to detect BPD was assessed in a receiver operating characteristic (ROC) analysis and calculated sensitivity and specificity at relevant cut-off points, determined by the Youden Index. 21 Data were analysed with SPSS 24.0 (SPSS Inc., Chicago, IL, USA) and a P-value of <0.05 was considered significant.
RESULTS
Patient characteristics
Data were available for 150 patients collected over a 30-month period (August 2014-February 2017), although data were incomplete for some components of assessment (e.g. n = 22 unable to undertake 6MWT, see Table 1 ). The cohort was predominantly female (69%) with a mean (SD) age of 43 (14) years and an elevated BMI at 32 (7) kg/m 2 ( Table 1) . At time of referral, all patients were prescribed at least Global initiative for asthma (GINA) step 4 asthma treatment (Table 1) and 97% patients report frequent use (>4 course in past year) or maintenance of oral corticosteroid.
As expected, patients were highly symptomatic with a low mean (SD) AQLQ of 3.4 (1.2) and heightened breathlessness indices; raised median (range) D12 at 19 (0-36) and mean (SD) NQ at 29.7 (12.5). Patients also had impaired exercise capacity with a group median (range) 6MWTD of 400 (14-675) m (67% predicted). Of the total population, 113 (76%) had an NQ ≥23, that is, in studies would be classified as having DB.
Following the systematic assessment of asthma, patients were characterized into three groups: asthmaonly (n = 54, 36%), asthma + BPD (n = 63, 42%) and BPD-only (n = 33, 22%) (Table 1) , that is, BPD was present in 54% (n = 63/117) of patients with asthma. There was no significant difference in age or BMI between the groups, whereas the BPD-only group had a greater proportion of female (85%) patients than the other groups (P < 0.05).
As expected, groups including patients with asthma had impaired lung function whilst spirometric indices were normal in the BPD-only group (Table 1) . Despite these differences, AQLQ was lower in those with asthma + BPD when compared with the BPD-only (P = 0.03) and the asthma-only groups (P < 0.01). Exercise capacity was also lowest in those with asthma + BPD (P < 0.05).
There was no difference in overall NQ score or proportion of NQ-positive patients (i.e. score ≥ 23) between the groups (Table 1 ). The proportion of BPDpositive patients was 77 of 113 (68%) in the NQ-positive group and 19 of 36 (53%) in the NQ-negative group.
BPAT score between groups
The median (range) BPAT score for the whole cohort was 5 (0-14). In the whole cohort, females had a slightly higher BPAT score at 5 (1-14) compared with males at 4 (0-13) (P = 0.04). There was no relationship Numbers are mean (SD) unless otherwise stated. Incomplete data for spirometry (n = 6), 6MWTD (n = 22), RR (n = 11), NQ (n = 1), D12 (n = 2) and AQLQ (n = 25).
*P < 0.05 and **P < 0.01 compared with 'asthma-only' group. + P < 0.05 and between BPAT and age or pulmonary function (P > 0.05).
The BPAT score was greater in patient groups with coexisting BPD (i.e. BPD-only and asthma + BPD) ( Fig. 1 ) and importantly patients with asthma but without BPD scored lower on BPAT than those with concurrent BPD (P < 0.01) (Fig. 1) . When the population was divided by NQ (i.e. by a cut-off point at ≥23), there was no significant difference in BPAT (P = 0.06).
There was a direct, but weak, relationship between BPAT score and both D12 (R 2 = 0.05, P < 0.01) and NQ score (R 2 = 0.04, P < 0.01) and a stronger relationship with RR (R 2 = 0.38, P < 0.01), whilst there was an inverse relationship with AQLQ (R 2 = 0.1, P < 0.01) (Fig. 2) .
Patients with airflow obstruction (n = 79) (i.e. forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC) < 0.7) had a lower median (range) BPAT score at 4 (0-12) than patients with no airflow obstruction at 5 (1-14) (P < 0.01), while there were no differences in 6MWTD % predicted, NQ score, D12, AQLQ or RR (all P > 0.05).
Utility of BPAT in differentiating BPD
The ability of the BPAT to detect BPD was assessed using an ROC curve (Fig. 3) . The area under the curve (AUC) was 0.88 (95% CI: 0.81-0.94) with an optimal BPAT score cut-off of ≥4 corresponding to a sensitivity of 0.92 and a specificity of 0.75 for diagnosis of BPD. Additional cut-off scores in the BPAT are depicted in Table 2 , with corresponding sensitivities and specificities. In the BPD-only group, 94% (n = 31/33) were BPAT positive (i.e. ≥4) whilst, for the asthma-only group, only 24% (n = 13/54) were positive and for the BPD + asthma group 91% (57/63) were positive. In individuals with an NQ ≥ 23 (i.e. usual means of diagnosing DB), 80 of 113 (71%) had a BPAT score of ≥4.
DISCUSSION
In a cohort of adults, completing a systematic assessment for treatment-refractory asthma, we found a high prevalence of BPD diagnosed by specialist respiratory physiotherapists. Indeed, BPD was detected in approximately two-thirds of the whole study cohort and in half of patients with objective evidence of coexisting asthma. We also found that a simple semiobjective screening tool, the BPAT, can be used to characterize and quantify the key features of BPD and thus has utility in differentiating coexisting BPD in this setting.
Identifying co-morbid conditions in treatmentrefractory asthma is important to ensure precise diagnosis and assessment of disease control in order to facilitate the optimum approach to treatment. 2 In this respect, a robust multidisciplinary assessment process in the work-up of suspected severe asthma is vital to identify BPD and to promote interventions that may otherwise be overlooked, for example, specialist physiotherapy treatment.
It is well recognized that DB is a prevalent comorbidity in asthma, with previous studies reporting DB present in approximately 50% of patients. 6 Historically, however, evaluation of this problem has been confounded by a diagnostic approach dependent on questionnaire-based tools, for example, an NQ score ≥23. Accordingly, there has been concern that the heightened prevalence of DB observed may have arisen as a consequence of an overlap in symptoms between asthma and DB, thus providing poor discrimination. 10 In this study, utilizing both a questionnaire-based approach and direct specialist physiotherapy assessment, we still detected a high prevalence of DB/BPD. More specifically, we found that DB was present in 113 (75%) in the total cohort, when based on a questionnaire approach utilizing the NQ, and in 96 (64%) individuals, when based on physiotherapy diagnosis. There was, however, a poor agreement between patients identified by questionnaire (i.e. NQ) and those identified by physiotherapy assessment, overall highlighting the importance of a direct physiotherapy assessment and close observation for the features of BPD. This disconnect may be explained by the fact that several of the constituent components of the NQ score positive with highly non-specific clinical features.
In this context, it appears that the BPAT offers the potential to serve a key function in identifying the core features present in BPD. Indeed, our sensitivity analysis indicates that a BPAT score of <4 may be useful in ruling out BPD, albeit in this specialist setting. This aligns with our clinical impression that these individuals are less likely to require or anecdotally to respond to physiotherapy intervention.
Hagman et al. 22 previously described the utility of a 10-criterion tool to assess DB in individuals with respiratory symptoms and asthma. This list was developed following expert discussion between specialists in allergology and physiotherapy and consensus taken that a score of over 5 was a reasonable diagnostic level. A number of the core criteria features overlap with those described in the BPAT (e.g. increased RR and features of air hunger) underpinning the importance of quantifying these core features. Moreover, breathing retraining (one to four sessions) in the group identified by this tool was associated with a significant improvement in respiratory symptoms, a reduction in hospital attendance and improved quality of life. 23 Clearly, it Detecting BPD in asthma will be important to study whether the BPAT can also provide similar power to define a group that will respond most favourably to breathing re-training intervention. Clearly, the BPAT score represents a 'snapshot' view of breathing pattern undertaken during a one-off assessment and the regularity of breathing pattern can change over time. Moreover, it remains unknown how the BPAT score, recorded in the resting state, relates to breathing dysregulation that may develop during exercise and contribute to the development of exertional dyspnoea. Regardless, in the current study, the coexistence of BPD, identified at rest, was associated with an impaired walking test performance; that is, those with asthma + BPD had a reduced walking test distance than those with asthma-alone, despite similar spirometric indices.
The finding that almost one-fourth of the study cohort (n = 33) referred with treatment-refractory symptoms were ultimately felt to have BPD-only (i.e. without current evidence of asthma causing symptoms), following their systematic assessment, highlights the importance of this assessment process. Clearly, making a diagnosis of asthma following a one-off assessment is not entirely secure and airway function and inflammation may fluctuate over time; however, this subgroup of patients had preserved lung function and there was an absence of airway inflammation. The SARA process permitted identification of contributory factors and acted to facilitate targeted appropriate therapy. This is vitally important in a time with a greater availability in biological therapy. Moreover, the presence of BPD appears to be associated with heightened Bold values indicate that a BPAT score of < 4 may be useful in ruling out BPD.
perception of respiratory symptoms/impaired quality of life and exercise tolerance.
Breathing pattern irregularities are observed in individuals with both acute and chronic airflow obstruction. Indeed, gas trapping and airflow constraint have immediate consequences for thoracic mechanics. However, in this study, we found no significant difference in either the prevalence of BPD or a greater BPAT score in those with airflow obstruction. Indeed, BPAT score was slightly higher in those with more preserved lung function.
As outlined in the Introduction, the clinical assessment of breathing pattern is difficult and concern is often raised regarding the potential influence of the assessor on an individual's breathing pattern. This is akin to the Hawthorne effect 24 in the assessment of any clinical measurement, that is, the direct influence of the observer on the measure of interest. Certainly, this is likely to be true of any technique. Some assessment methods previously reported in the assessment of DB are dependent on a direct contact assessment (e.g. the manual assessment of respiratory motion (MARM) technique). The MARM has however been validated against other means of evaluating respiratory movement (e.g. respiratory inductance plethysmography) and appears to be responsive to treatment. 25 The MARM evaluates respiratory movement from a posterior perspective and thus may negate influence of the assessor on the patient. This remains to be evaluated and certainly an advantage of the BPAT is its ability to be collated from a rapid assimilation of the standard components from a respiratory physiotherapy assessment. Moreover, it does not require marker placement or the use of other direct technology (e.g. respiratory bands). In this context, it is also hoped that the BPAT will facilitate clinical consideration of BPD; however, more work is needed to determine how easy it is to use for those without experience in this field. Work is also now needed to determine the responsiveness of the BPAT to breathing control physiotherapy intervention, as performed with the MARM.
In the current study, we did not evaluate the impact or contribution from potential upper airway dysfunction, for example, inducible laryngeal obstruction. Certainly, induced laryngeal obstruction (ILO) is recognized to be an important co-morbidity contributing to symptoms in refractory asthma.
2 Accordingly, some authors have proposed that classification should differentiate and identify extrathoracic causes of BPD. 26 Likewise, there are classification systems that aim to describe and characterize the different subtypes of DB based on breathing regularity but at this time it is not clear how these relate to the BPAT and further work is needed to assess the relationship between the BPAT and ILO.
A limitation of work in this field is the lack of a robust 'gold standard' for the diagnosis of BPD. We compared BPAT score with diagnostic impression of BPD from an expert respiratory physiotherapist. However, it is important to note that the BPAT score was not utilized to establish the diagnosis of BPAT. In this study, patient assessment was conducted by several different respiratory physiotherapists; however, we appreciate that future work is needed to validate interobserver and within-patient repeatability of the BPAT prospectively in a blinded fashion, for example, possibly with video recordings and separate assessors. Future studies should include this approach to assessment and comparison with other measures of breathing pattern, for example, using cardiopulmonary exercise data. The ability of the BPAT to predict response to physiotherapy intervention will also inform its 'diagnostic' value. Indeed, clearly, these studies are vitally important to ensure the BPAT can be used in a diagnostic clinical setting.
The study findings also represent a retrospective assessment of individuals assessed in the service over the timeframe highlighted. Clearly, there were some missing data points and our estimates of prevalence must acknowledge the limitations inherent to this type of approach to analysis.
Likewise, our classification for having asthma was based on the outcome of the MDT appraisal process in a tertiary asthma service. This currently represents the gold standard means of assessing severe treatmentrefractory asthma; however, as this was a pragmatic observational study appraising our routine practice, patients did not complete a prospective comprehensive panel of objective tests to evaluate asthma. The potential impact of improved asthma control with changes in anti-inflammatory treatment may indeed improve indices of BPD; however, the BPAT potentially offers a tool to assess the impact of these changes. Further detailed work to address validity in a prospective study addressing these issues is important in the future and for further studies using this tool in other less specialist centres to further explore relationships with BPAT.
In conclusion, BPD is prevalent in treatmentrefractory asthma and heightens symptom perception and impairs quality of life. The BPAT provides a simple and rapid way to characterize BPD in treatmentrefractory asthma. The assessment is easy to complete and can prompt need for physiotherapy assessment AE intervention to optimize respiratory symptom management. Further work is now needed to validate this tool prospectively and assess response to intervention.
